SavedAdd your journal

Journals / İnfeksiyon Dergisi / 2004 / Cilt: 18 - Sayı: 4

A case of toxic epidermal necrolysis treated with high-dose steroid

Yüksek doz steroit tedavisi ile iyileşen bir toksik epidermal nekroliz olgusu

Ali OLUT
Seçkin KARACAN
Şükran KÖSE
Gülgün AKKOÇLU
Pages
521–523
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

There was no history of medication usage, and the patient responded well to steroid therapy, which is contraversiai in the literature.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:A 40-year-old male patient with toxic epidermal necrolysis that occured after an upper respiratory tract infection is presented.
📊
Key Findings & Data:A 40-year-old male patient with toxic epidermal necrolysis that occured after an upper respiratory tract infection is presented.
💡
Conclusion & Impact:There was no history of medication usage, and the patient responded well to steroid therapy, which is contraversiai in the literature.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

A 40-year-old male patient with toxic epidermal necrolysis that occured after an upper respiratory tract infection is presented. There was no history of medication usage, and the patient responded well to steroid therapy, which is contraversiai in the literature.

Özet

İlaç kullanım öyküsü olmadan, bir üst solunum yolu infeksiyonunu takiben gelişen ve literatürde tartışmalı olan steroid tedavisi ile iyileşen toksik epidermal nekrolizli olan 40 yaşındaki erkek olgu sunulmuştur.

🔖

Cite This Article

OLUT, A., KARACAN, S., KÖSE, Ş., AKKOÇLU, G. (2022). A case of toxic epidermal necrolysis treated with high-dose steroid. İnfeksiyon Dergisi, Cilt: 18 - Sayı: 4, 521–523. https://ajindex.com/articles/546573

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (8)

  1. Chan HL, Stern RS, Arndt KA, et al. The incidence of erythema multiforme, Stevens-Johnson syndrome, and toxic epidermal necroiysis. A population-based study with particular reference to reactions caused by drugs among outpatients. Arch Dermatol 1990; 126:43-7
  2. Roujeau JC, Kelly JP, Naldi L, et al. Medication use and the risk of Stevens-Johnson syndrome or toxic epidermal necroiysis. N Engl J Med 1995;333:1600-7
  3. Cleah LL, Roujeau JC. Toxic shock syndrome. J Dermatol Treaf998; 4:17-9
  4. Ghislain PD., Roujeau JC. Treatment of severe drug reactions: Stevens-Johnson Syndrome, toxic epidermal necroiysis and hypersensitivity syndrome. Dermatology Online Journal 2002; 8: 5 5. Viard I, Wehrli P, Bullani R, et al. Inhibition of toxic epidermal necroiysis by blockade of CD95 with human intravenous immunoglobulin. Science 1998; 282: 490-3
  5. Wolkenstein P, Latarjet J, Roujeau JC, et al. Randomised comparison of thalidomide versus placebo in toxic epidermal necroiysis. Lancet 1998; 352: 1586-9
  6. Tegelberg-Stassen MJ, van Vloten WA, de la Faille B. Management of non-staphylococcal toxic epidermal necroiysis: follow-up study of 16 case histories. Dermatologica 1990; 180:124-9
  7. Halebian PH, Corder VJ, Madden MR, Finklestein JL, Shires GT. Improved bum center survival of patients with toxic epidermal necroiysis managed without corticosteroids. Ann Surg 1986; 204: 503-2
  8. Kim PS, Goldfarb IW, Gaisford JC, Slater H. Stevens-Johnson syndrome and toxic epidermal necroiysis: a pathophysiologic review with recommendations for a treatment protocol. J Burn Care Rehabil 1983; 4: 91-100.